ACPU
VRTX icon

Arrowgrass Capital Partners (US)’s Vertex Pharmaceuticals VRTX Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-199,200
Closed -$24M – 470
2015
Q3 		$20.7M Buy
199,200
+117,200
+143% +$15.1M 0.39% 48
2015
Q2 		$10.1M Buy
82,000
+54,500
+198% +$6.87M 0.15% 135
2015
Q1 		$3.24M Buy
27,500
+12,500
+83% +$1.5M 0.05% 206
2014
Q4 		$1.78M Sell
15,000
-5,000
-25% -$563K 0.03% 255
2014
Q3 		$2.25M Buy
+20,000
New +$1.9M 0.05% 174
2013
Q4 		– Sell
-282,332
Closed -$21.4M – 197
2013
Q3 		$21.4M Buy
+282,332
New +$22.5M 0.8% 32

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return